Sales and Marketing

Showing 15 posts of 11527 posts found.

Novartis ponders Horsham site future

April 14, 2014 Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site

Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …

GSK bribery controversy spreads to Poland

April 14, 2014 Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq

Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …

How can ‘innovation’ be defined?

April 14, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, NHS, UK, eric low, innovation, myeloma

Innovation has been and continues to be an important topic of discussion for a number of different stakeholders and disciplines …

EMA to conduct major review into testosterone drugs

April 14, 2014 Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

Roche/Novartis offices raided over anti-competitive activities

April 11, 2014 Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD

French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …

Pfizer’s Jonathan Emms becomes new ABPI president

April 11, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, Pfizer, jonathan emms

Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …

NICE to look again at Tamiflu after data saga

April 11, 2014 Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu

The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …

Merck gets hep C boost as competition ramps up

April 11, 2014 Research and Development, Sales and Marketing Merck, daclatasvir, hep C, sovaldi

Merck has released promising data from a trial which uses two of its investigational compounds to treat patients with hepatitis …

Herceptin faces UK competition within months

April 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biocon, Herceptin, Hospira, Perjeta, breast cancer

Roche’s blockbuster breast cancer drug Herceptin may soon be under threat from copycat treatments after a court in the UK …

Regulatory woes eclipse Sun Pharma deal

April 10, 2014 Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma

The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …

Tamiflu stockpiling ‘unjustifiable’ and wasted £424m

April 10, 2014 Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials

Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …

DIA appoints Dr Haijun Dong as MD for DIA China

April 10, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing dia

Biopharmaceutical executive Dr Haijun (Lou) Dong has been named as the new managing director for DIA China. “Dr Dong brings …

Boehringer: ‘devil in detail’ on new drug pricing policy

April 10, 2014 Medical Communications, Sales and Marketing Boehringer, PPRS, VBP, Zinta Krumins, alltrials, vba

Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …

NHS needs to understand drug costs better, says ABPI

April 10, 2014 Medical Communications, Research and Development, Sales and Marketing ABPI, AGNSS, Deepak Khanna, NICE, Stephen Whitehead, Tarceva, soliris

The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …
The Gateway to Local Adoption Series

Latest content